4.7 Article

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Microbiology

Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19

Qirui Guo et al.

Summary: The study reveals that infection with SARS-CoV-2 leads to immune dysregulation, with the specific inhibitor Paquinimod showing potential in rescuing the infection and improving survival rates. This highlights new therapeutic opportunities for COVID-19 treatment.

CELL HOST & MICROBE (2021)

Article Immunology

Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19

Enrico Brunetta et al.

Summary: In patients with severe COVID-19, elevated levels of long pentraxin PTX3 have been found to be a strong predictor of decreased survival. Myelomonocytic cells and endothelial cells in both blood and lung tissue are major sources of PTX3, with PTX3 plasma concentration serving as an independent prognostic indicator for short-term mortality in COVID-19 patients.

NATURE IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

Yu Zuo et al.

Summary: COVID-19 patients have elevated levels of tPA and PAI-1 in plasma, which are correlated with neutrophil counts and respiratory status. Particularly high levels of tPA are strongly associated with mortality and enhanced fibrinolysis, suggesting a subset of patients may have a favorable balance of factors for fibrinolysis. Further investigation into tPA as a biomarker is warranted.

SCIENTIFIC REPORTS (2021)

Article Medicine, Research & Experimental

An immune-based biomarker signature is associated with mortality in COVID-19 patients

Michael S. Abers et al.

Summary: Immune and inflammatory responses are important factors contributing to disease severity in COVID-19. This study identified specific immune-based biomarkers associated with mortality in COVID-19 patients, with some biomarkers consistently higher in those who died compared to those who recovered, suggesting their potential for early prediction of disease outcome.

JCI INSIGHT (2021)

Article Medical Laboratory Technology

Circulating calprotectin as biomarker in neutrophil-related inflammation: Pre-analytical recommendations and reference values according to sample type

Marnix Mylemans et al.

Summary: The study aimed to establish reference values for circulating CLP in different sample types, and found that baseline CLP concentrations in serum were higher than in EDTA and citrate plasma. Pre-analytical variables were evaluated, showing that heparin, EDTA, and citrate stabilized CLP concentrations for up to 6 hours before centrifugation.

CLINICA CHIMICA ACTA (2021)

Article Immunology

The Inflammatory Factors Associated with Disease Severity to Predict COVID-19 Progression

Wei Huang et al.

Summary: COVID-19 is associated with immune dysregulation and cytokine storm, leading to altered levels of various immune cells and cytokines in the body. Some specific factors could potentially be used as biomarkers for predicting disease severity and progression.

JOURNAL OF IMMUNOLOGY (2021)

Review Medicine, General & Internal

Calprotectin, an Emerging Biomarker of Interest in COVID-19: A Systematic Review and Meta-Analysis

Raphael Udeh et al.

Summary: Calprotectin levels are significantly elevated in COVID-19 patients who develop severe form of the disease and have prognostic importance.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Hematology

Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19

Erica Villa et al.

Summary: This study found that angiopoietin-2 could serve as an important predictor for in-hospital mortality and nonresolving pulmonary condition in COVID-19 patients. Dynamic assessment of angiopoietin-2 levels may provide early disease prediction information.

BLOOD ADVANCES (2021)

Letter Infectious Diseases

Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department

Wolfgang Bauer et al.

JOURNAL OF INFECTION (2021)

Article Biochemical Research Methods

Longitudinal proteomic profiling provides insights into host response and proteome dynamics in COVID-19 progression

Jee-Soo Lee et al.

Summary: This study identified potential early prognostic protein markers and 40 potential biomarkers that reflect the clinical progression of COVID-19. These findings provide insights into host response to SARS-CoV-2 infection and may support better prediction and monitoring of progression to severe COVID-19.

PROTEOMICS (2021)

Article Biochemical Research Methods

A predictive paradigm for COVID-19 prognosis based on the longitudinal measure of biomarkers

Xin Chen et al.

Summary: It is crucial to predict the prognosis of individual COVID-19 patients in guiding treatment. This study utilized historical regression trees and joint modeling technique to model the longitudinal trajectories of laboratory biomarkers, making dynamic predictions for individual prognosis. Important biomarkers associated with COVID-19 patients' prognosis were identified and dynamic predictions at the individual level were obtained.

BRIEFINGS IN BIOINFORMATICS (2021)

Article Multidisciplinary Sciences

Virus-induced senescence is a driver and therapeutic target in COVID-19

Soyoung Lee et al.

Summary: Virus-induced senescence is a key pathogenic feature in COVID-19, and senolytic drugs, which induce apoptosis of senescent cells, can alleviate disease severity in COVID-19 patients, as demonstrated in hamsters and mice infected with SARS-CoV-2.

NATURE (2021)

Article Biochemistry & Molecular Biology

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev et al.

Summary: This study investigates the time-dependent progression of COIVD-19 inpatients by measuring diagnostic parameters and plasma proteomes, revealing an initial spike in inflammatory response followed by tissue repair and immunomodulation. Prognostic marker signatures for treatment strategies were identified and machine learning models based on proteome show transferability to independent cohorts.

CELL SYSTEMS (2021)

Article Immunology

Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID-19 deaths

Paul Bastard et al.

Summary: Autoantibodies neutralizing interferons are present in a significant percentage of critical COVID-19 patients, especially in older individuals, and their prevalence increases with age.

SCIENCE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin et al.

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Article Multidisciplinary Sciences

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Qian Zhang et al.

SCIENCE (2020)

Article Cell Biology

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients

Roberta Angioni et al.

CELL DEATH & DISEASE (2020)

Article Computer Science, Interdisciplinary Applications

Estimation of Extended Mixed Models Using Latent Classes and Latent Processes: The R Package lcmm

Cecile Proust-Lima et al.

JOURNAL OF STATISTICAL SOFTWARE (2017)

Article Rheumatology

Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis

H. Cypers et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Review Rheumatology

Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review

Mads Abildtrup et al.

JOURNAL OF RHEUMATOLOGY (2015)